Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder

NCT07480525 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT07480525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07480525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Recruiting
Start date
March 20, 2026
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder